Valuation (64%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.99 | N/A |
| PEG Ratio (TTM) | -17.90 | N/A |
| P/S Ratio (TTM) | 3.72 | N/A |
| P/B Ratio (TTM) | 1.38 | N/A |
| P/FCF Ratio (TTM) | 7.01 | N/A |
| Price to 5YR AVG Earnings Ratio | 13.51 | N/A |
| Price to 5YR AVG FCF Ratio | 9.98 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.91% | N/A |
| ROE (TTM) | 9.76% | N/A |
| Net Profit Margin (TTM) | 24.94% | N/A |
| ROIC 5YR AVG | 19.51% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 7.89% | 14.29% | 8.84% |
| Revenue | 1.37% | 6.02% | 5.96% |
| Net Income | 5.34% | 5.59% | 3.12% |
| Cash Flow | 1,060.54% | 4.01% | 9.85% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.21 | N/A |
| Quick Ratio (TTM) | 0.21 | N/A |
| D/E Ratio (TTM) | 1.22 | N/A |
| Interest Coverage (TTM) | 1.21 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 9.46 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.99% | N/A |